Coave Therapeutics Launches coAAV-CSF-01, a Novel CNS-Targeted Gene Therapy Vector for Neurodegenerative and other CNS Diseases. Coave Therapeutics . Fri, May 9, 2025, 1:30 PM 3 min read.

Targeted Oncology is pleased to announce this year’s first recipient of the Oncology Icons award, Sanjay K. Juneja, M.D. CRANBURY, N.J., April 23, 2024 (GLOBE NEWSWIRE) -- Targeted Oncology ...